Does RIFAMPIN Cause Hepatocellular injury? 212 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 212 reports of Hepatocellular injury have been filed in association with RIFAMPIN (Rifampin). This represents 1.6% of all adverse event reports for RIFAMPIN.
212
Reports of Hepatocellular injury with RIFAMPIN
1.6%
of all RIFAMPIN reports
6
Deaths
140
Hospitalizations
How Dangerous Is Hepatocellular injury From RIFAMPIN?
Of the 212 reports, 6 (2.8%) resulted in death, 140 (66.0%) required hospitalization, and 12 (5.7%) were considered life-threatening.
Is Hepatocellular injury Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIFAMPIN. However, 212 reports have been filed with the FAERS database.
What Other Side Effects Does RIFAMPIN Cause?
Drug ineffective (1,238)
Drug reaction with eosinophilia and systemic symptoms (1,049)
Drug interaction (735)
Pyrexia (735)
Acute kidney injury (684)
Drug-induced liver injury (684)
Off label use (640)
Condition aggravated (597)
Nausea (572)
Paradoxical drug reaction (570)
What Other Drugs Cause Hepatocellular injury?
ACETAMINOPHEN (1,761)
METHOTREXATE (683)
ATORVASTATIN (610)
SULFAMETHOXAZOLE\TRIMETHOPRIM (415)
ENOXAPARIN (365)
TRAMADOL (349)
AMOXICILLIN (347)
ESOMEPRAZOLE (341)
PANTOPRAZOLE (340)
VINCRISTINE (306)
Which RIFAMPIN Alternatives Have Lower Hepatocellular injury Risk?
RIFAMPIN vs RIFAMYCIN
RIFAMPIN vs RIFAPENTINE
RIFAMPIN vs RIFAXIMIN
RIFAMPIN vs RILMENIDINE
RIFAMPIN vs RILONACEPT